EXPERIENCE IN USING INTRAVENOUS THROMBOLYSIS IN ISCHEMIC STROKE
https://doi.org/10.14412/2074-2711-2010-69
Abstract
The authors' experience leads to the conclusion that intravenous thrombolytic therapy (TLT) is highly effective and should be introduced into the routine practical work of vascular departments. It is stressed that the success of this treatment for ischemic stroke in the therapeutic window period is associated with the adherence to the uniform patient selection criteria and management protocols after TLT; moreover, it is important to keep in mind the characteristics of each patient.
About the Authors
T. V. Demin
Kazan State Medical University;
Interregional Clinical Diagnostic Center
Russian Federation
Kazan
Russian Federation
Kazan
M. V. Saikhunov
Kazan State Medical University;
Interregional Clinical Diagnostic Center
Russian Federation
Kazan
Russian Federation
Kazan
D. R. Khasanova
Kazan State Medical University;
Interregional Clinical Diagnostic Center
Russian Federation
Kazan
Russian Federation
Kazan
References
1. <div><p>Хасанова Д.Р., Сайхунов М.В., Дeмин Т.В. и др. Опыт реканализационной терапии у больных с ишемическим инсультом в условиях Межрегионального клинико-диагностического центра, г. Казань. Журн неврол и психиатр им. С.С. Корсакова (приложение Инсульт) 2008;22:22-9.</p><p>Adams H., Bendixen B., Kappelle J. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:1:35-40.</p><p>National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.</p><p>Wintermark M., Reichhart M., Thiran J. et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002;51:417-32.</p><p>Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. Cerebrovasc Dis 2008;25:457-507.</p><p>Хасанова Д.Р., Сайхунов М.В., Демин Т.В. Факторы, влияющие на постреканализационный период при тромболитической терапии ишемического инсульта. Некоторые аспекты нейропротекции при тромболизисе. Сб. материалов I Национального конгресса Кардионеврология М., 2008;122-4.</p><p>The International Stroke Thrombolysis Register for Safe Implementation of thrombolysis in Stroke (SITS). 2001 European Stroke Conference.</p><p>Alexandrov A.V., Demchuk A.M., Burgin W.S. et al. Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST Trial. J Neuroimaging 2004;14:113-7.</p><p>Hacke W., Kaste M., Fieschi C. et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-51.</p><p>Hacke W., Kaste M., Bluhmki E. et al. Thrombolysis with Alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.</p></div><br />
Review
For citations:
Demin T.V., Saikhunov M.V., Khasanova D.R. EXPERIENCE IN USING INTRAVENOUS THROMBOLYSIS IN ISCHEMIC STROKE. Neurology, Neuropsychiatry, Psychosomatics. 2010;2(1):42-47. (In Russ.) https://doi.org/10.14412/2074-2711-2010-69
Views: 782
Email this article 